Results 71 to 80 of about 38,863 (158)
Antiplatelet agents and proton pump inhibitors – personalizing treatment
, 2010 Eugene Lin, Rajiv Padmanabhan, Majaz MoonisDepartment of Neurology, University of Massachusetts Medical School and UMass Memorial Medical Center, Worcester, Massachusetts, USAIntroduction: Antiplatelet therapy remains one of the cornerstones in the ...
Eugene Lin +2 more
core
, 2017 Comparison between antiplatelet naïve patients and patients with prior and/or acute antiplatelet therapy†.
Agnieszka Slezak (3663094) +10 more
core +1 more source
Antiplatelet agents for stroke prevention
, 2000 Antiplatelet agents for stroke ...
Gallai V, Paciaroni M
core +1 more source
The role of green tea intake in thromboprophylaxis of venous thromboembolism in patients with cancer
Frontiers in NutritionBackgroundGreen tea intake has been reported to improve the clinical outcomes of patients with cardiovascular diseases or cancer. It may have a certain role in the development of venous thromboembolism (VTE) among cancer patients. The current study aimed
Qihuan Yao +10 more
doaj +1 more source
Review: Antiplatelet Drugs: What Comes Next?
, 2010 Antiplatelet drugs are important components in the management of atherothrombotic vascular disease. However, several limitations restrict the safety and efficacy of current antiplatelet therapy in clinical practice.
Matilda Florentin +4 more
core +1 more source
New oral antiplatelet medications
, 2017 New and more potent oral antiplatelet agents have shown better clinical outcomes over the last few years. This article reviews the latest oral antiplatelet therapies available, their indications and contraindications, genetic resistance, and major drug ...
Jeffords, Travis, Travis Jeffords
core +1 more source
Synthesis, Antiplatelet and Vasorelaxing Activities of Xanthone Derivatives
, 2010 A series of omega-aminoalkoxylxanthones was synthesized and tested in vitro for their ability to inhibit platelet aggregation and cause vasorelaxing action.
HUNG, CHI-FENG;SHIEH, BOR-JINN;YANG, SHYH-CHYUN;TENG, CHE-MING;LIN, CHUN-NAN +1 more
core
, 2020 Platelets are essential factor in the pathophysiology of atherothrombosis, abnormal platelet function guiding to many cardiovascular complications such as myocardial infarction and ischemic stroke.
Ali Murtadha Haider +3 more
core +1 more source
Ticagrelor versus clopidogrel in the management of acute myocardial infarction
Journal of Community Hospital Internal Medicine Perspectives, 2019 Hypothesis: In the care of acute myocardial infarction, ticagrelor attenuates post-ischemic myocardial damage and inhibits platelet activity to a greater extent than clopidogrel.
Candice Volney +2 more
doaj +1 more source